 |
Eli Lilly and Co. and BioMS Medical Corp. said on 27 July 2009 that their experimental treatment for MS has failed to delay progression of the disease in a late-stage trial and that they would discontinue all ongoing studies of the product.
To read more, as reported by the UK MS Trust, click here.
Source: UK MS Trust
|
